Contact Helius

The Portable Neuromodulation Stimulator (PoNS^®) is an authorized medical device in the US. The PoNS device is indicated for use as a short-term treatment of gait deficit due to mild to moderate symptoms from multiple sclerosis (MS) and is to be used as an adjunct to a supervised therapeutic exercise program in patients aged 22 and older by prescription only.

PoNS™ is an authorized medical device commercially available in Canada intended for use as a short-term treatment (14 weeks) of gait deficit due to mild to moderate symptoms from MS and is to be used in conjunction with physical therapy. The device is also intended for use as a short-term treatment (14 weeks) of chronic balance deficit due to mild to moderate traumatic brain injury (mmTBI) and is to be used in conjunction with physical therapy.

PoNS^® is authorized in Australia (AUS TGA) as a non-implantable neurostimulator intended for short-term use by healthcare professionals as an adjunct to a therapeutic exercise program to improve balance and gait. It is not yet commercially available.